ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Basic/Clinical Science Session

Drug and Device Repurposing: Expanding the Therapeutic Armamentarium for Children with CKD

October 24, 2020 | 10:00 AM - 12:00 PM

Location: On-Demand

Session Description

Advances in genome technology have significantly improved our understanding of the pathogenesis of different childhood kidney diseases. This understanding lets us consider the use of existing therapy and devices approved for other conditions to treat CKD in children and adults. This session discusses potential and existing therapeutic targets in the treatment of children with CKD.

ASN thanks the American Society of Pediatric Nephrology for assistance with this session.

Learning Objective(s)

  • Outline the steps involved in identifying new therapeutic targets and repurposing existing agents in the treatment of nephrotic syndrome and IgA nephropathy
  • Discuss novel therapeutic targets for CKD-MBD
  • Describe new therapeutic targets for membranous nephropathy

Learning Pathway(s)

  • Development and Pediatrics
  • Glomerular Diseases

Moderators

  • Jennifer G. Jetton, MD
  • William E. Smoyer, MD

Presentations

  • Drug Repurposing in Nephrotic Syndrome: "One Family at a Time"
    10:00 AM - 10:30 AM
    Gentzon Hall, MD, PhD
  • Drug Repurposing in IgA Nephropathy: From Risk Loci to Therapy
    10:30 AM - 11:00 AM
    Krzysztof Kiryluk, MD
  • New Therapeutic Targets for Membranous Nephropathy
    11:00 AM - 11:30 AM
    David J. Salant, MD, MBChB
  • Novel Therapy for CKD-MBD
    11:30 AM - 12:00 PM
    Jyothsna Gattineni, MD